Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 206099

ONZETRA XSAIL (SUMATRIPTAN SUCCINATE)
EQ 11MG BASE Marketing Status: Prescription

Active Ingredient: SUMATRIPTAN SUCCINATE
Proprietary Name: ONZETRA XSAIL
Dosage Form; Route of Administration: POWDER; INHALATION
Strength: EQ 11MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N206099
Product Number: 001
Approval Date: Jan 27, 2016
Applicant Holder Full Name: AVANIR PHARMACEUTICALS
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English